Ploughshare Innovations, a Defence Science and Technology Laboratory (Dstl) spin-out firm, has funded the development of a revolutionary test that has the potential to predict whether coronavirus patients will develop Sepsis before symptoms appear.<a href="“><img class="alignright wp-image-136065 size-full" src="” alt=”coronavirus screening at medical centre” width=”300″ height=”195″ />

£200,000 of initial seed funding has been awarded to Presymptom Health, a medical diagnostics company in Wiltshire founded by scientists to develop ground-breaking innovations in the medical testing arena.